Affiliation:
1. National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority (EAEA)
Abstract
Abstract
Background
Hepatitis C Virus (HCV), Hepatitis B Virus (HBV), and Human Immunodeficiency Virus 1 (HIV-1) are epidemic blood-borne viruses, pose threats to human health and cause economic losses to nations for combating their infection transmission. However, the diagnostic methodologies which depend on the detection of viral nucleic acid are much expensive but more accurate than immunological testing.
Methods
This study approaches a lower cost triplex PCR method for simultaneous detection of the nucleic acids (genomes) of the three mentioned viruses. This PCR targets amplification of a short conserved region, having distinguishable melting profile and electrophoretic molecular weight, inside each viral genome. Therefore, this diagnostic method will be applicable with both conventional PCR (combined with electrophoresis) and real time PCR facilities. Many in silico investigations have been conducted to prove the capability of the approached PCR to detect variants of each virus. Then, Egyptian isolates of each virus have been subjected for the laboratory application of the given protocol.
Results
The results revealed good sensitivity for detecting and discriminating low copies of each type of viral particles.
Conclusions
The given protocol presents a sensitive PCR diagnostic test, with less time and cost those are ordinary needed for detecting three types of viruses. This will be a good substitutive system for the mistakable immunological-based tests.
Publisher
Research Square Platform LLC
Reference22 articles.
1. Karoney MJ, Siika AM. Hepatitis C virus (HCV) infection in Africa: a review. Pan African medical journal. 2013 May 1;14(1).
2. Omran D, Alboraie M, Zayed RA, Wifi MN, Naguib M, Eltabbakh M, Abdellah M, Sherief AF, Maklad S, Eldemellawy HH, Saad OK. Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations. World journal of gastroenterology. 2018 Oct 14;24(38):4330.
3. Ohnuma H, Tanaka T, Yoshikawa A, Murokawa H, Minegishi K, Yamanaka R, Lizuka HY, Miyamoto M, Satoh S, Nakahira S. The first large-scale nucleic acid amplification testing (NAT) of donated blood using multiplex reagent for simultaneous detection of HBV, HCV, and HIV‐1 and significance of NAT for HBV. Microbiology and immunology. 2001 Sep;45(9):667–72.
4. Kheirabad AK, Farshidfar G, Gouklani H. Cross Reactivity Values in Hepatitis C Infection and a Solution to Detect True Positive Serums by Third Generation of ELISA Test.International Journal of Medical Research & Health Sciences. 2016;5(9):81–9.
5. Sánchez-Herrero A, Nieto-Benito LM, Rosell-Díaz AM, Pulido-Pérez A. False-Positive Serology for Hepatitis B After Intravenous Immunoglobulin Therapy for Toxic Epidermal Necrolysis. Actas dermo-sifiliograficas. 2021 April: S0001-7310. DOI: 10.1016/j.adengl.2019.10.013